Table of Content

1 Report Overview
1.1 Inhaled Corticosteroid Definition
1.2 Market by Type
1.2.1 Global Inhaled Corticosteroid Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Beclomethasone Dipropionate
1.2.3 Budesonide
1.2.4 Fluticasone Inhaler Powder
1.2.5 Mometasone
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Inhaled Corticosteroid Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Respiratory Care Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Inhaled Corticosteroid Sales
2.1 Global Inhaled Corticosteroid Revenue Estimates and Forecasts 2018-2034
2.2 Global Inhaled Corticosteroid Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Inhaled Corticosteroid Revenue by Region
2.3.1 Global Inhaled Corticosteroid Revenue by Region (2018-2023)
2.3.2 Global Inhaled Corticosteroid Revenue by Region (2024-2034)
2.4 Global Inhaled Corticosteroid Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Inhaled Corticosteroid Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Inhaled Corticosteroid Sales Quantity by Region
2.6.1 Global Inhaled Corticosteroid Sales Quantity by Region (2018-2023)
2.6.2 Global Inhaled Corticosteroid Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Inhaled Corticosteroid Sales Quantity by Manufacturers
3.1.1 Global Inhaled Corticosteroid Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Inhaled Corticosteroid Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Inhaled Corticosteroid Sales in 2024
3.2 Global Inhaled Corticosteroid Revenue by Manufacturers
3.2.1 Global Inhaled Corticosteroid Revenue by Manufacturers (2018-2023)
3.2.2 Global Inhaled Corticosteroid Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Inhaled Corticosteroid Revenue in 2024
3.3 Global Inhaled Corticosteroid Sales Price by Manufacturers
3.4 Global Key Players of Inhaled Corticosteroid, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Inhaled Corticosteroid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Inhaled Corticosteroid, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Inhaled Corticosteroid, Product Offered and Application
3.8 Global Key Manufacturers of Inhaled Corticosteroid, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Inhaled Corticosteroid Sales Quantity by Type
4.1.1 Global Inhaled Corticosteroid Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Inhaled Corticosteroid Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Inhaled Corticosteroid Sales Quantity Market Share by Type (2018-2034)
4.2 Global Inhaled Corticosteroid Revenue by Type
4.2.1 Global Inhaled Corticosteroid Historical Revenue by Type (2018-2023)
4.2.2 Global Inhaled Corticosteroid Forecasted Revenue by Type (2024-2034)
4.2.3 Global Inhaled Corticosteroid Revenue Market Share by Type (2018-2034)
4.3 Global Inhaled Corticosteroid Price by Type
4.3.1 Global Inhaled Corticosteroid Price by Type (2018-2023)
4.3.2 Global Inhaled Corticosteroid Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Inhaled Corticosteroid Sales Quantity by Application
5.1.1 Global Inhaled Corticosteroid Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Inhaled Corticosteroid Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Inhaled Corticosteroid Sales Quantity Market Share by Application (2018-2034)
5.2 Global Inhaled Corticosteroid Revenue by Application
5.2.1 Global Inhaled Corticosteroid Historical Revenue by Application (2018-2023)
5.2.2 Global Inhaled Corticosteroid Forecasted Revenue by Application (2024-2034)
5.2.3 Global Inhaled Corticosteroid Revenue Market Share by Application (2018-2034)
5.3 Global Inhaled Corticosteroid Price by Application
5.3.1 Global Inhaled Corticosteroid Price by Application (2018-2023)
5.3.2 Global Inhaled Corticosteroid Price Forecast by Application (2024-2034)
6 North America
6.1 North America Inhaled Corticosteroid Sales by Company
6.1.1 North America Inhaled Corticosteroid Revenue by Company (2018-2023)
6.1.2 North America Inhaled Corticosteroid Sales Quantity by Company (2018-2023)
6.2 North America Inhaled Corticosteroid Market Size by Type
6.2.1 North America Inhaled Corticosteroid Sales Quantity by Type (2018-2034)
6.2.2 North America Inhaled Corticosteroid Revenue by Type (2018-2034)
6.3 North America Inhaled Corticosteroid Market Size by Application
6.3.1 North America Inhaled Corticosteroid Sales Quantity by Application (2018-2034)
6.3.2 North America Inhaled Corticosteroid Revenue by Application (2018-2034)
6.4 North America Inhaled Corticosteroid Market Size by Country
6.4.1 North America Inhaled Corticosteroid Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Inhaled Corticosteroid Revenue by Country (2018-2034)
6.4.3 North America Inhaled Corticosteroid Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Inhaled Corticosteroid Sales by Company
7.1.1 Europe Inhaled Corticosteroid Sales Quantity by Company (2018-2023)
7.1.2 Europe Inhaled Corticosteroid Revenue by Company (2018-2023)
7.2 Europe Inhaled Corticosteroid Market Size by Type
7.2.1 Europe Inhaled Corticosteroid Sales Quantity by Type (2018-2034)
7.2.2 Europe Inhaled Corticosteroid Revenue by Type (2018-2034)
7.3 Europe Inhaled Corticosteroid Market Size by Application
7.3.1 Europe Inhaled Corticosteroid Sales Quantity by Application (2018-2034)
7.3.2 Europe Inhaled Corticosteroid Revenue by Application (2018-2034)
7.4 Europe Inhaled Corticosteroid Market Size by Country
7.4.1 Europe Inhaled Corticosteroid Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Inhaled Corticosteroid Revenue by Country (2018-2034)
7.4.3 Europe Inhaled Corticosteroid Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Inhaled Corticosteroid Sales by Company
8.1.1 China Inhaled Corticosteroid Sales Quantity by Company (2018-2023)
8.1.2 China Inhaled Corticosteroid Revenue by Company (2018-2023)
8.2 China Inhaled Corticosteroid Market Size by Type
8.2.1 China Inhaled Corticosteroid Sales Quantity by Type (2018-2034)
8.2.2 China Inhaled Corticosteroid Revenue by Type (2018-2034)
8.3 China Inhaled Corticosteroid Market Size by Application
8.3.1 China Inhaled Corticosteroid Sales Quantity by Application (2018-2034)
8.3.2 China Inhaled Corticosteroid Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Inhaled Corticosteroid Sales by Company
9.1.1 APAC Inhaled Corticosteroid Sales Quantity by Company (2018-2023)
9.1.2 APAC Inhaled Corticosteroid Revenue by Company (2018-2023)
9.2 APAC Inhaled Corticosteroid Market Size by Type
9.2.1 APAC Inhaled Corticosteroid Sales Quantity by Type (2018-2034)
9.2.2 APAC Inhaled Corticosteroid Revenue by Type (2018-2034)
9.3 APAC Inhaled Corticosteroid Market Size by Application
9.3.1 APAC Inhaled Corticosteroid Sales Quantity by Application (2018-2034)
9.3.2 APAC Inhaled Corticosteroid Revenue by Application (2018-2034)
9.4 APAC Inhaled Corticosteroid Market Size by Region
9.4.1 APAC Inhaled Corticosteroid Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Inhaled Corticosteroid Revenue by Region (2018-2034)
9.4.3 APAC Inhaled Corticosteroid Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Inhaled Corticosteroid Sales by Company
10.1.1 Middle East, Africa and Latin America Inhaled Corticosteroid Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Inhaled Corticosteroid Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Inhaled Corticosteroid Market Size by Type
10.2.1 Middle East, Africa and Latin America Inhaled Corticosteroid Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Inhaled Corticosteroid Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Inhaled Corticosteroid Market Size by Application
10.3.1 Middle East, Africa and Latin America Inhaled Corticosteroid Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Inhaled Corticosteroid Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Inhaled Corticosteroid Market Size by Country
10.4.1 Middle East, Africa and Latin America Inhaled Corticosteroid Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Inhaled Corticosteroid Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Inhaled Corticosteroid Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Sumitomo
11.1.1 Sumitomo Company Information
11.1.2 Sumitomo Overview
11.1.3 Sumitomo Inhaled Corticosteroid Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Sumitomo Inhaled Corticosteroid Products and Services
11.1.5 Sumitomo Inhaled Corticosteroid SWOT Analysis
11.1.6 Sumitomo Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Inhaled Corticosteroid Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Pfizer Inhaled Corticosteroid Products and Services
11.2.5 Pfizer Inhaled Corticosteroid SWOT Analysis
11.2.6 Pfizer Recent Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Overview
11.3.3 Novartis Inhaled Corticosteroid Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Novartis Inhaled Corticosteroid Products and Services
11.3.5 Novartis Inhaled Corticosteroid SWOT Analysis
11.3.6 Novartis Recent Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Overview
11.4.3 Merck Inhaled Corticosteroid Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Merck Inhaled Corticosteroid Products and Services
11.4.5 Merck Inhaled Corticosteroid SWOT Analysis
11.4.6 Merck Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Inhaled Corticosteroid Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Sanofi Inhaled Corticosteroid Products and Services
11.5.5 Sanofi Inhaled Corticosteroid SWOT Analysis
11.5.6 Sanofi Recent Developments
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Company Information
11.6.2 Johnson and Johnson Overview
11.6.3 Johnson and Johnson Inhaled Corticosteroid Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Johnson and Johnson Inhaled Corticosteroid Products and Services
11.6.5 Johnson and Johnson Inhaled Corticosteroid SWOT Analysis
11.6.6 Johnson and Johnson Recent Developments
11.7 GSK
11.7.1 GSK Company Information
11.7.2 GSK Overview
11.7.3 GSK Inhaled Corticosteroid Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 GSK Inhaled Corticosteroid Products and Services
11.7.5 GSK Inhaled Corticosteroid SWOT Analysis
11.7.6 GSK Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Overview
11.8.3 AstraZeneca Inhaled Corticosteroid Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 AstraZeneca Inhaled Corticosteroid Products and Services
11.8.5 AstraZeneca Inhaled Corticosteroid SWOT Analysis
11.8.6 AstraZeneca Recent Developments
11.9 Teijin
11.9.1 Teijin Company Information
11.9.2 Teijin Overview
11.9.3 Teijin Inhaled Corticosteroid Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Teijin Inhaled Corticosteroid Products and Services
11.9.5 Teijin Inhaled Corticosteroid SWOT Analysis
11.9.6 Teijin Recent Developments
11.10 Glaxo's Advair
11.10.1 Glaxo's Advair Company Information
11.10.2 Glaxo's Advair Overview
11.10.3 Glaxo's Advair Inhaled Corticosteroid Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Glaxo's Advair Inhaled Corticosteroid Products and Services
11.10.5 Glaxo's Advair Inhaled Corticosteroid SWOT Analysis
11.10.6 Glaxo's Advair Recent Developments
11.11 Amgen
11.11.1 Amgen Company Information
11.11.2 Amgen Overview
11.11.3 Amgen Inhaled Corticosteroid Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Amgen Inhaled Corticosteroid Products and Services
11.11.5 Amgen Recent Developments
11.12 Kos Pharmaceutical
11.12.1 Kos Pharmaceutical Company Information
11.12.2 Kos Pharmaceutical Overview
11.12.3 Kos Pharmaceutical Inhaled Corticosteroid Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Kos Pharmaceutical Inhaled Corticosteroid Products and Services
11.12.5 Kos Pharmaceutical Recent Developments
11.13 Teva Pharmaceutical
11.13.1 Teva Pharmaceutical Company Information
11.13.2 Teva Pharmaceutical Overview
11.13.3 Teva Pharmaceutical Inhaled Corticosteroid Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Teva Pharmaceutical Inhaled Corticosteroid Products and Services
11.13.5 Teva Pharmaceutical Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Inhaled Corticosteroid Value Chain Analysis
12.2 Inhaled Corticosteroid Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Inhaled Corticosteroid Production Mode & Process
12.4 Inhaled Corticosteroid Sales and Marketing
12.4.1 Inhaled Corticosteroid Sales Channels
12.4.2 Inhaled Corticosteroid Distributors
12.5 Inhaled Corticosteroid Customers
13 Market Dynamics
13.1 Inhaled Corticosteroid Industry Trends
13.2 Inhaled Corticosteroid Market Drivers
13.3 Inhaled Corticosteroid Market Challenges
13.4 Inhaled Corticosteroid Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Inhaled Corticosteroid Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Beclomethasone Dipropionate
Table 3. Major Manufacturers of Budesonide
Table 4. Major Manufacturers of Fluticasone Inhaler Powder
Table 5. Major Manufacturers of Mometasone
Table 6. Major Manufacturers of Others
Table 7. Global Inhaled Corticosteroid Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Inhaled Corticosteroid Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Inhaled Corticosteroid Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Inhaled Corticosteroid Revenue Market Share by Region (2018-2023)
Table 11. Global Inhaled Corticosteroid Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Inhaled Corticosteroid Revenue Market Share by Region (2024-2034)
Table 13. Global Inhaled Corticosteroid Sales Quantity by Region: 2018 VS 2024 VS 2034 (MT)
Table 14. Global Inhaled Corticosteroid Sales by Region (2018-2023) & (MT)
Table 15. Global Inhaled Corticosteroid Sales Market Share by Region (2018-2023)
Table 16. Global Inhaled Corticosteroid Sales by Region (2024-2034) & (MT)
Table 17. Global Inhaled Corticosteroid Sales Market Share by Region (2024-2034)
Table 18. Global Inhaled Corticosteroid Sales Quantity by Manufacturers (2018-2023) & (MT)
Table 19. Global Inhaled Corticosteroid Sales Quantity Share by Manufacturers (2018-2023)
Table 20. Global Inhaled Corticosteroid Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Inhaled Corticosteroid Revenue Share by Manufacturers (2018-2023)
Table 22. Global Inhaled Corticosteroid Price by Manufacturers 2018-2023 (USD/MT)
Table 23. Global Key Players of Inhaled Corticosteroid, Industry Ranking, 2021 VS 2024
Table 24. Global Inhaled Corticosteroid Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Inhaled Corticosteroid by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inhaled Corticosteroid as of 2024)
Table 26. Global Key Manufacturers of Inhaled Corticosteroid, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Inhaled Corticosteroid, Product Offered and Application
Table 28. Global Key Manufacturers of Inhaled Corticosteroid, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Inhaled Corticosteroid Sales Quantity by Type (2018-2023) & (MT)
Table 31. Global Inhaled Corticosteroid Sales Quantity by Type (2024-2034) & (MT)
Table 32. Global Inhaled Corticosteroid Sales Quantity Share by Type (2018-2023)
Table 33. Global Inhaled Corticosteroid Sales Quantity Share by Type (2024-2034)
Table 34. Global Inhaled Corticosteroid Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Inhaled Corticosteroid Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Inhaled Corticosteroid Revenue Share by Type (2018-2023)
Table 37. Global Inhaled Corticosteroid Revenue Share by Type (2024-2034)
Table 38. Inhaled Corticosteroid Price by Type (2018-2023) & (USD/MT)
Table 39. Global Inhaled Corticosteroid Price Forecast by Type (2024-2034) & (USD/MT)
Table 40. Global Inhaled Corticosteroid Sales Quantity by Application (2018-2023) & (MT)
Table 41. Global Inhaled Corticosteroid Sales Quantity by Application (2024-2034) & (MT)
Table 42. Global Inhaled Corticosteroid Sales Quantity Share by Application (2018-2023)
Table 43. Global Inhaled Corticosteroid Sales Quantity Share by Application (2024-2034)
Table 44. Global Inhaled Corticosteroid Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Inhaled Corticosteroid Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Inhaled Corticosteroid Revenue Share by Application (2018-2023)
Table 47. Global Inhaled Corticosteroid Revenue Share by Application (2024-2034)
Table 48. Inhaled Corticosteroid Price by Application (2018-2023) & (USD/MT)
Table 49. Global Inhaled Corticosteroid Price Forecast by Application (2024-2034) & (USD/MT)
Table 50. North America Inhaled Corticosteroid Revenue by Company (2018-2023) & (US$ Million)
Table 51. North America Inhaled Corticosteroid Sales Quantity by Company (2018-2023) & (MT)
Table 52. North America Inhaled Corticosteroid Sales Quantity by Type (2018-2023) & (MT)
Table 53. North America Inhaled Corticosteroid Sales Quantity by Type (2024-2034) & (MT)
Table 54. North America Inhaled Corticosteroid Revenue by Type (2018-2023) & (US$ Million)
Table 55. North America Inhaled Corticosteroid Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Inhaled Corticosteroid Sales Quantity by Application (2018-2023) & (MT)
Table 57. North America Inhaled Corticosteroid Sales Quantity by Application (2024-2034) & (MT)
Table 58. North America Inhaled Corticosteroid Revenue by Application (2018-2023) & (US$ Million)
Table 59. North America Inhaled Corticosteroid Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Inhaled Corticosteroid Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 61. North America Inhaled Corticosteroid Revenue by Country (2018-2023) & (US$ Million)
Table 62. North America Inhaled Corticosteroid Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Inhaled Corticosteroid Sales Quantity by Country (2018-2023) & (MT)
Table 64. North America Inhaled Corticosteroid Sales Quantity by Country (2024-2034) & (MT)
Table 65. Europe Inhaled Corticosteroid Sales Quantity by Company (2018-2023) & (MT)
Table 66. Europe Inhaled Corticosteroid Revenue by Company (2018-2023) & (US$ Million)
Table 67. Europe Inhaled Corticosteroid Sales Quantity by Type (2018-2023) & (MT)
Table 68. Europe Inhaled Corticosteroid Sales Quantity by Type (2024-2034) & (MT)
Table 69. Europe Inhaled Corticosteroid Revenue by Type (2018-2023) & (US$ Million)
Table 70. Europe Inhaled Corticosteroid Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Inhaled Corticosteroid Sales Quantity by Application (2018-2023) & (MT)
Table 72. Europe Inhaled Corticosteroid Sales Quantity by Application (2024-2034) & (MT)
Table 73. Europe Inhaled Corticosteroid Revenue by Application (2018-2023) & (US$ Million)
Table 74. Europe Inhaled Corticosteroid Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Inhaled Corticosteroid Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 76. Europe Inhaled Corticosteroid Revenue by Country (2018-2023) & (US$ Million)
Table 77. Europe Inhaled Corticosteroid Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Inhaled Corticosteroid Sales Quantity by Country (2018-2023) & (MT)
Table 79. Europe Inhaled Corticosteroid Sales Quantity by Country (2024-2034) & (MT)
Table 80. China Inhaled Corticosteroid Sales Quantity by Company (2018-2023) & (MT)
Table 81. China Inhaled Corticosteroid Revenue by Company (2018-2023) & (US$ Million)
Table 82. China Inhaled Corticosteroid Sales Quantity by Type (2018-2023) & (MT)
Table 83. China Inhaled Corticosteroid Sales Quantity by Type (2024-2034) & (MT)
Table 84. China Inhaled Corticosteroid Revenue by Type (2018-2023) & (US$ Million)
Table 85. China Inhaled Corticosteroid Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Inhaled Corticosteroid Sales Quantity by Application (2018-2023) & (MT)
Table 87. China Inhaled Corticosteroid Sales Quantity by Application (2024-2034) & (MT)
Table 88. China Inhaled Corticosteroid Revenue by Application (2018-2023) & (US$ Million)
Table 89. China Inhaled Corticosteroid Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Inhaled Corticosteroid Sales Quantity by Company (2018-2023) & (MT)
Table 91. APAC Inhaled Corticosteroid Revenue by Company (2018-2023) & (US$ Million)
Table 92. APAC Inhaled Corticosteroid Sales Quantity by Type (2018-2023) & (MT)
Table 93. APAC Inhaled Corticosteroid Sales Quantity by Type (2024-2034) & (MT)
Table 94. APAC Inhaled Corticosteroid Revenue by Type (2018-2023) & (US$ Million)
Table 95. APAC Inhaled Corticosteroid Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Inhaled Corticosteroid Sales Quantity by Application (2018-2023) & (MT)
Table 97. APAC Inhaled Corticosteroid Sales Quantity by Application (2024-2034) & (MT)
Table 98. APAC Inhaled Corticosteroid Revenue by Application (2018-2023) & (US$ Million)
Table 99. APAC Inhaled Corticosteroid Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Inhaled Corticosteroid Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 101. APAC Inhaled Corticosteroid Revenue by Region (2018-2023) & (US$ Million)
Table 102. APAC Inhaled Corticosteroid Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Inhaled Corticosteroid Sales Quantity by Region (2018-2023) & (MT)
Table 104. APAC Inhaled Corticosteroid Sales Quantity by Region (2024-2034) & (MT)
Table 105. Middle East, Africa and Latin America Inhaled Corticosteroid Sales Quantity by Company (2018-2023) & (MT)
Table 106. Middle East, Africa and Latin America Inhaled Corticosteroid Revenue by Company (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Inhaled Corticosteroid Sales Quantity by Type (2018-2023) & (MT)
Table 108. Middle East, Africa and Latin America Inhaled Corticosteroid Sales Quantity by Type (2024-2034) & (MT)
Table 109. Middle East, Africa and Latin America Inhaled Corticosteroid Revenue by Type (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America Inhaled Corticosteroid Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Inhaled Corticosteroid Sales Quantity by Application (2018-2023) & (MT)
Table 112. Middle East, Africa and Latin America Inhaled Corticosteroid Sales Quantity by Application (2024-2034) & (MT)
Table 113. Middle East, Africa and Latin America Inhaled Corticosteroid Revenue by Application (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Inhaled Corticosteroid Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Inhaled Corticosteroid Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Inhaled Corticosteroid Revenue by Country (2018-2023) & (US$ Million)
Table 117. Middle East, Africa and Latin America Inhaled Corticosteroid Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Inhaled Corticosteroid Sales Quantity by Country (2018-2023) & (MT)
Table 119. Middle East, Africa and Latin America Inhaled Corticosteroid Sales Quantity by Country (2024-2034) & (MT)
Table 120. Sumitomo Company Information
Table 121. Sumitomo Description and Overview
Table 122. Sumitomo Inhaled Corticosteroid Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 123. Sumitomo Inhaled Corticosteroid Product and Services
Table 124. Sumitomo Inhaled Corticosteroid SWOT Analysis
Table 125. Sumitomo Recent Developments
Table 126. Pfizer Company Information
Table 127. Pfizer Description and Overview
Table 128. Pfizer Inhaled Corticosteroid Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 129. Pfizer Inhaled Corticosteroid Product and Services
Table 130. Pfizer Inhaled Corticosteroid SWOT Analysis
Table 131. Pfizer Recent Developments
Table 132. Novartis Company Information
Table 133. Novartis Description and Overview
Table 134. Novartis Inhaled Corticosteroid Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 135. Novartis Inhaled Corticosteroid Product and Services
Table 136. Novartis Inhaled Corticosteroid SWOT Analysis
Table 137. Novartis Recent Developments
Table 138. Merck Company Information
Table 139. Merck Description and Overview
Table 140. Merck Inhaled Corticosteroid Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 141. Merck Inhaled Corticosteroid Product and Services
Table 142. Merck Inhaled Corticosteroid SWOT Analysis
Table 143. Merck Recent Developments
Table 144. Sanofi Company Information
Table 145. Sanofi Description and Overview
Table 146. Sanofi Inhaled Corticosteroid Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 147. Sanofi Inhaled Corticosteroid Product and Services
Table 148. Sanofi Inhaled Corticosteroid SWOT Analysis
Table 149. Sanofi Recent Developments
Table 150. Johnson and Johnson Company Information
Table 151. Johnson and Johnson Description and Overview
Table 152. Johnson and Johnson Inhaled Corticosteroid Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 153. Johnson and Johnson Inhaled Corticosteroid Product and Services
Table 154. Johnson and Johnson Inhaled Corticosteroid SWOT Analysis
Table 155. Johnson and Johnson Recent Developments
Table 156. GSK Company Information
Table 157. GSK Description and Overview
Table 158. GSK Inhaled Corticosteroid Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 159. GSK Inhaled Corticosteroid Product and Services
Table 160. GSK Inhaled Corticosteroid SWOT Analysis
Table 161. GSK Recent Developments
Table 162. AstraZeneca Company Information
Table 163. AstraZeneca Description and Overview
Table 164. AstraZeneca Inhaled Corticosteroid Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 165. AstraZeneca Inhaled Corticosteroid Product and Services
Table 166. AstraZeneca Inhaled Corticosteroid SWOT Analysis
Table 167. AstraZeneca Recent Developments
Table 168. Teijin Company Information
Table 169. Teijin Description and Overview
Table 170. Teijin Inhaled Corticosteroid Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 171. Teijin Inhaled Corticosteroid Product and Services
Table 172. Teijin Inhaled Corticosteroid SWOT Analysis
Table 173. Teijin Recent Developments
Table 174. Glaxo's Advair Company Information
Table 175. Glaxo's Advair Description and Overview
Table 176. Glaxo's Advair Inhaled Corticosteroid Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 177. Glaxo's Advair Inhaled Corticosteroid Product and Services
Table 178. Glaxo's Advair Inhaled Corticosteroid SWOT Analysis
Table 179. Glaxo's Advair Recent Developments
Table 180. Amgen Company Information
Table 181. Amgen Description and Overview
Table 182. Amgen Inhaled Corticosteroid Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 183. Amgen Inhaled Corticosteroid Product and Services
Table 184. Amgen Recent Developments
Table 185. Kos Pharmaceutical Company Information
Table 186. Kos Pharmaceutical Description and Overview
Table 187. Kos Pharmaceutical Inhaled Corticosteroid Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 188. Kos Pharmaceutical Inhaled Corticosteroid Product and Services
Table 189. Kos Pharmaceutical Recent Developments
Table 190. Teva Pharmaceutical Company Information
Table 191. Teva Pharmaceutical Description and Overview
Table 192. Teva Pharmaceutical Inhaled Corticosteroid Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 193. Teva Pharmaceutical Inhaled Corticosteroid Product and Services
Table 194. Teva Pharmaceutical Recent Developments
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Inhaled Corticosteroid Distributors List
Table 198. Inhaled Corticosteroid Customers List
Table 199. Inhaled Corticosteroid Market Trends
Table 200. Inhaled Corticosteroid Market Drivers
Table 201. Inhaled Corticosteroid Market Challenges
Table 202. Inhaled Corticosteroid Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Inhaled Corticosteroid Product Picture
Figure 2. Global Inhaled Corticosteroid Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Inhaled Corticosteroid Market Share by Type in 2024 & 2034
Figure 4. Beclomethasone Dipropionate Product Picture
Figure 5. Budesonide Product Picture
Figure 6. Fluticasone Inhaler Powder Product Picture
Figure 7. Mometasone Product Picture
Figure 8. Others Product Picture
Figure 9. Global Inhaled Corticosteroid Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 10. Global Inhaled Corticosteroid Market Share by Application in 2024 & 2034
Figure 11. Hospitals
Figure 12. Clinics
Figure 13. Respiratory Care Centers
Figure 14. Others
Figure 15. Inhaled Corticosteroid Report Years Considered
Figure 16. Global Inhaled Corticosteroid Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 17. Global Inhaled Corticosteroid Revenue 2018-2034 (US$ Million)
Figure 18. Global Inhaled Corticosteroid Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 19. Global Inhaled Corticosteroid Sales Quantity 2018-2034 (MT)
Figure 20. Global Inhaled Corticosteroid Sales Quantity Market Share by Region (2018-2023)
Figure 21. Global Inhaled Corticosteroid Sales Quantity Market Share by Region (2024-2034)
Figure 22. North America Inhaled Corticosteroid Sales Quantity YoY (2018-2034) & (MT)
Figure 23. North America Inhaled Corticosteroid Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Europe Inhaled Corticosteroid Sales Quantity YoY (2018-2034) & (MT)
Figure 25. Europe Inhaled Corticosteroid Revenue YoY (2018-2034) & (US$ Million)
Figure 26. China Inhaled Corticosteroid Sales Quantity YoY (2018-2034) & (MT)
Figure 27. China Inhaled Corticosteroid Revenue YoY (2018-2034) & (US$ Million)
Figure 28. APAC Inhaled Corticosteroid Sales Quantity YoY (2018-2034) & (MT)
Figure 29. APAC Inhaled Corticosteroid Revenue YoY (2018-2034) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Inhaled Corticosteroid Sales Quantity YoY (2018-2034) & (MT)
Figure 31. Middle East, Africa and Latin America Inhaled Corticosteroid Revenue YoY (2018-2034) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by Inhaled Corticosteroid Sales Quantity in 2024
Figure 33. The Top 10 and Top 5 Players Market Share by Inhaled Corticosteroid Revenue in 2024
Figure 34. Inhaled Corticosteroid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 35. Global Inhaled Corticosteroid Sales Quantity Market Share by Type (2018-2034)
Figure 36. Global Inhaled Corticosteroid Revenue Market Share by Type (2018-2034)
Figure 37. Global Inhaled Corticosteroid Sales Quantity Market Share by Application (2018-2034)
Figure 38. Global Inhaled Corticosteroid Revenue Market Share by Application (2018-2034)
Figure 39. North America Inhaled Corticosteroid Revenue Market Share by Company in 2024
Figure 40. North America Inhaled Corticosteroid Sales Quantity Market Share by Company in 2024
Figure 41. North America Inhaled Corticosteroid Sales Quantity Market Share by Type (2018-2034)
Figure 42. North America Inhaled Corticosteroid Revenue Market Share by Type (2018-2034)
Figure 43. North America Inhaled Corticosteroid Sales Quantity Market Share by Application (2018-2034)
Figure 44. North America Inhaled Corticosteroid Revenue Market Share by Application (2018-2034)
Figure 45. North America Inhaled Corticosteroid Revenue Share by Country (2018-2034)
Figure 46. North America Inhaled Corticosteroid Sales Quantity Share by Country (2018-2034)
Figure 47. U.S. Inhaled Corticosteroid Revenue (2018-2034) & (US$ Million)
Figure 48. Canada Inhaled Corticosteroid Revenue (2018-2034) & (US$ Million)
Figure 49. Europe Inhaled Corticosteroid Sales Quantity Market Share by Company in 2024
Figure 50. Europe Inhaled Corticosteroid Revenue Market Share by Company in 2024
Figure 51. Europe Inhaled Corticosteroid Sales Quantity Market Share by Type (2018-2034)
Figure 52. Europe Inhaled Corticosteroid Revenue Market Share by Type (2018-2034)
Figure 53. Europe Inhaled Corticosteroid Sales Quantity Market Share by Application (2018-2034)
Figure 54. Europe Inhaled Corticosteroid Revenue Market Share by Application (2018-2034)
Figure 55. Europe Inhaled Corticosteroid Revenue Share by Country (2018-2034)
Figure 56. Europe Inhaled Corticosteroid Sales Quantity Share by Country (2018-2034)
Figure 57. Germany Inhaled Corticosteroid Revenue (2018-2034) & (US$ Million)
Figure 58. France Inhaled Corticosteroid Revenue (2018-2034) & (US$ Million)
Figure 59. U.K. Inhaled Corticosteroid Revenue (2018-2034) & (US$ Million)
Figure 60. Italy Inhaled Corticosteroid Revenue (2018-2034) & (US$ Million)
Figure 61. Russia Inhaled Corticosteroid Revenue (2018-2034) & (US$ Million)
Figure 62. China Inhaled Corticosteroid Sales Quantity Market Share by Company in 2024
Figure 63. China Inhaled Corticosteroid Revenue Market Share by Company in 2024
Figure 64. China Inhaled Corticosteroid Sales Quantity Market Share by Type (2018-2034)
Figure 65. China Inhaled Corticosteroid Revenue Market Share by Type (2018-2034)
Figure 66. China Inhaled Corticosteroid Sales Quantity Market Share by Application (2018-2034)
Figure 67. China Inhaled Corticosteroid Revenue Market Share by Application (2018-2034)
Figure 68. APAC Inhaled Corticosteroid Sales Quantity Market Share by Company in 2024
Figure 69. APAC Inhaled Corticosteroid Revenue Market Share by Company in 2024
Figure 70. APAC Inhaled Corticosteroid Sales Quantity Market Share by Type (2018-2034)
Figure 71. APAC Inhaled Corticosteroid Revenue Market Share by Type (2018-2034)
Figure 72. APAC Inhaled Corticosteroid Sales Quantity Market Share by Application (2018-2034)
Figure 73. APAC Inhaled Corticosteroid Revenue Market Share by Application (2018-2034)
Figure 74. APAC Inhaled Corticosteroid Revenue Share by Region (2018-2034)
Figure 75. APAC Inhaled Corticosteroid Sales Quantity Share by Region (2018-2034)
Figure 76. Japan Inhaled Corticosteroid Revenue (2018-2034) & (US$ Million)
Figure 77. South Korea Inhaled Corticosteroid Revenue (2018-2034) & (US$ Million)
Figure 78. China Taiwan Inhaled Corticosteroid Revenue (2018-2034) & (US$ Million)
Figure 79. Southeast Asia Inhaled Corticosteroid Revenue (2018-2034) & (US$ Million)
Figure 80. India Inhaled Corticosteroid Revenue (2018-2034) & (US$ Million)
Figure 81. Middle East, Africa and Latin America Inhaled Corticosteroid Sales Quantity Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America Inhaled Corticosteroid Revenue Market Share by Company in 2024
Figure 83. Middle East, Africa and Latin America Inhaled Corticosteroid Sales Quantity Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Inhaled Corticosteroid Revenue Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Inhaled Corticosteroid Sales Quantity Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Inhaled Corticosteroid Revenue Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Inhaled Corticosteroid Sales Quantity Share by Country (2018-2034)
Figure 88. Middle East, Africa and Latin America Inhaled Corticosteroid Revenue Share by Country (2018-2034)
Figure 89. Brazil Inhaled Corticosteroid Revenue (2018-2034) & (US$ Million)
Figure 90. Mexico Inhaled Corticosteroid Revenue (2018-2034) & (US$ Million)
Figure 91. Turkey Inhaled Corticosteroid Revenue (2018-2034) & (US$ Million)
Figure 92. Israel Inhaled Corticosteroid Revenue (2018-2034) & (US$ Million)
Figure 93. GCC Countries Inhaled Corticosteroid Revenue (2018-2034) & (US$ Million)
Figure 94. Inhaled Corticosteroid Value Chain
Figure 95. Inhaled Corticosteroid Production Process
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed